This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Intraosseous Infusion Devices Market

Market Insights on Intraosseous Infusion Devices covering sales outlook, demand forecast & up-to-date key trends

Intraosseous Infusion Devices Market by Product (B.I.G, FAST1, EZ-IO, FASTR, IO Needles), Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus), Technology (Manual, Automatic), End User & Region - Forecast to 2021 - 2031

Intraosseous Infusion Devices Market Snapshot

[193 Pages Report] According to Future Market Insights (FMI), the global intraosseous infusion device was valued at US$ 3.5 Bn in 2020 and is expected to reach US$ 7.9 Bn by 2031, at a CAGR of 7.6% over the forecast period (2021-2031).  

Amidst soaring competition, Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Beckon Dickinson and Co. have emerged as top market players. FMI has projected these companies to account for over half of the global market share in 2021.     

Market Outlook:

Data Points

Market Insights

Intraosseous Infusion Market Value 2020

US$ 3.5 Bn

Intraosseous Infusion Market Value 2031

US$ 7.9 Bn

CAGR 2021-2031

7.6%

Share of Top 5 countries

51%

Key Players

Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Beckon Dickinson and Co.

Customize this Report

Let us know your requirement to get
100% FREE customization

How will the Intraosseous Infusion Market Outlook for 2021-2031 compare to 2016-2020?

According to Future Market Insights (FMI), the sales of the intraosseous infusion device have grown at a CAGR of nearly 5.6% between 2016 and 2020. Increasing research on emergency medical care portfolio globally will result in impressive sales prospects over the coming years.

According to FMI, the intraosseous infusion devices market holds nearly 19% of the US$ 18.5 Bn worth global market for infusion devices. The demand for intraosseous devices will continue increasing through the forecast period. 

For instance, air support for immediate medical emergency services is the new outlook in 911 services and has been appreciated by the other emergency health professionals and the local population.

The upcoming air emergency medical service is to be equipped with a variety of emergency medical devices such as a ventilator, cardiac monitor, burn packs, IV pumps, cervical collars and obstetric kit along with intraosseous infusion devices.

Intraosseous Infusion Devices Market Download Report Brochure

The upcoming policy is expected to drive the intraosseous infusion devices market. Infusion of drugs through the bone using intraosseous devices is more cost-effective and can be done more efficiently as compared to intravenous catheters in hospital settings.

Manufacturers are investing in research and development activities to develop IO devices that can be used in hospital settings to initiate instant care to patients. Mergers and acquisitions together with extensive R&D initiatives for strengthening product portfolio are key strategies adopted by companies to increase their revenue.

For Instance, On Dec 18, Cook Medical Incorporated announced the acquisition of Whitaker Park Development Authority Inc. that once manufactured cigarettes but henceforth will be manufacturing intraosseous infusion devices for better care of the patients.

The market is consolidated and is dominated by players such as include, Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.

Future Market Insights expects the global market for intraosseous infusion devices to grow at a CAGR of 7.6% between 2021 and 2031. The growth is attributable to the rising number of research and development activities undertaken by market players to expand their presence and strengthen product portfolios.

How is Rising Demand for Emergency Healthcare Affecting Intraosseous Infusion Devices Market?

IO Devices are designed to maximize efficiency, safety, eliminate unnecessary services and decrease treatment time. A sedentary lifestyle has also determined the growth of the market as it causes various illnesses which incudes, last stage renal diseases, COPD, urological diseases, cardiovascular diseases, etc. Such chronic clinical conditions have brought demand in the vascular access devices in the forecast period.

Emergency medical care is considered as pre-hospital or ambulatory transportation aid for road accident victims and those who have sustained life-threatening injuries for which, immediate medical intervention is required. Lack of structural models in medical aid leads to ineffective medical care. These factors, along with the rising number of emergency cases globally is expected to raise demand for efficient emergency medical services and in turn, is underpinning the intraosseous infusion device market.

According to the American Heart Association report, 2015, compiled with data from the Centers for Disease Control and Prevention, the National Institutes of Health and other government sources, cardiovascular disease is the leading cause for death globally, associated with 17.3 Mn deaths per year, which is further expected to increase to 23.6 Mn by 2030 end.

Vascular access products fill an important void in emergency medical services and contribute significantly towards the annual revenue of various major medical devices manufacturers. The ease and immediate effect through vascular access have helped considerably high number of patients requiring immediate medication intervention.

According to an Elsevier/Journal of Emergency Medical Services (JEMS) editorial supplement sponsored by VidaCare, IO infusion supported vascular access of drugs positively and provided rapid vascular access in 250 patients with a success rate of 97%. The study supports the significance of the need for vascular access and is expected to favour the growth of the intraosseous infusion market shortly

Over the recent years, there has been a significant upsurge in the number of emergency medical cases in response to rising demand from patients, physicians and insurers. Rapid technological advancements have led to various medical procedures being carried out using vascular access devices.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is The Rising Number of Traumatic Surgeries Affecting Intraosseous Infusion Devices Market Growth?

There are two components involved in community care, care during transportation and care in the healthcare facility. In emergency medical departments a patient can be brought in a severe life threatening condition, be it severe burns, road traffic accidents or cardiac arrest, where sometimes it is difficult to find for an IV point or it becomes difficult when the venous system is collapsed. This in turn is need for intraosseous infusion devices in the market.

A rising number of traumatic surgeries especially in pediatric patients has been reported in the past few decades, which is further expected to support the intraosseous infusion devices based market growth.

According to the Royal College of Surgeons, 2014, a document on emergency surgery policy briefing states that approximately 25% of patients were admitted in an emergency in 2012-2013 with 32% of trauma and orthopaedic surgery collectively. The rate of patient readmission increased by 27.1% from 2002-03 to reach 11.5% in 2012-13

The American College of Surgeons Advanced Trauma Life Support Manual (ATLS) 1997, has suggested the use of intraosseous infusion in children up to 6 years of age during traumatic situations like a circulatory failure or after two failed attempts of intravenous access.

What is the Impact of the COVID-19 Crisis on the Market?

Due to COVID 19, there has been a gradual rise in the market growth across intraosseous infusion devices segment. During the pandemic, there has been an increase in the number of emergency medical services where instant treatment was necessary. Furthermore, clinical conditions that needed instant care/ attention such as severe burns, accidents or trauma where IV access is not possible at that particular time and IO devices helps rapid infusion of fluids and medicines. This has let the demand for IO devices to boost. 

Narayana health org. in July 2020 stated that stroke can be a manifestation whilst covid-19 and 0.9% to 23% COVID-19 patients developed stroke. Hemorrhagic and ischemic stroke are the types of stroke seen in Covid-19 patients.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. Intraosseous Infusion Devices Market Continue Leading North America?

In 2021, the U.S. is estimated to account for over 53.1% value share in North America. The demand is increasing in the U.S due to the increasing number of emergency medical cases that focus on delivering the highest quality and instant care to the patients.

Why is Russia Intraosseous Infusion Devices Market Considered Highly Lucrative within Europe?

Russia is expected to account for nearly 14.3% of the market in Europe. The rise in demand for intraosseous infusion devices in Russia is primarily due to the increasing aging population, rising cases of chronic diseases and presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios are likely to offer exciting opportunities for the intraosseous infusion device in Russia.

What are the Factors Supporting Intraosseous Infusion Devices Sales in China?

The China market is expected to account for over 38.0% of the market share in East Asia through the forecast period. The increasing use of IO Devices, with advancement in technology, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practices and other therapeutics are the primary factors driving growth in China.

Sales in China are also influenced by domestic market impact factors such as regulatory change, favorable government policies and growing funding which affects current and future market trends.

Category-wise Insights

Why is the demand for EZ-IO Product Rising?

In terms of product, EZ-IO intraosseous infusion devices hold the maximum share of over 20% in 2021, expanding at 7.6% CAGR during the forecast period. Growth registered in this category is due to its quick response and surety of easy intraosseous accessibility within 30 seconds.

Why is Sternum Route of Administration Preferred in Intraosseous Infusion Devices Market?

In terms of route of administration, the Sternum segment accounts for 30.8% of the market share in 2021, indicating prevalence of high demand for high-quality care specificity when compared with the Distal & Proximal Tibia. This trend is expected to continue during the forecast period as well.

How Will Sales of Automatic Intraosseous Infusion Devices Fare?

By technology, the automatic infusion devices market accounts for 50.8% of the market share in 2021. The demand in this segment will continue rising. It is primarily preferred by the patients when they need instant care.

Who is the Leading End User of Intraosseous Infusion Devices?

By end user, EMS and hospitals together will account for more than 60.0% of the market share in 2021.  The rising demand for IO devices with various advancements and harnessing new scientific advances is likely to fuel the segment.

Competitive Landscape

Companies manufacturing intraosseous infusion devices are actively seeking to strengthen their position through various strategic planning such as collaborations, merger & acquisition partnerships, FDA approvals and agreements with established as well as emerging market players. These strategies will help manufacturers capitalize on available opportunities in the market:

In July 2020, Aero Healthcare acquired Clayton First Aid creating a window where they can expand themselves into intraosseous infusion devices

The greater the demand for active service, the stronger is the end product, which will lead to increased demand for the market. Leading industry players are focusing on the development and launch of the technologically advanced service portfolio. There are huge opportunities for the market players to invest in intraosseous infusion device s

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD Million for Value.

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Product, Route of Administration, Technology, End User and Region

Key Companies Profiled

  • Pyng Medical Corp.,
  • Cook Medical Incorporated,
  • PerSys Medical,
  • Aero Healthcare,
  • Teleflex, Inc.,
  • Becton Dickinson and Co

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Intraosseous Infusion Devices - Market by Category

Product:

  • B.I.G
  • FAST1
  • EZ-IO
  • FASTR
  • IO Needles
  • Others

By Route of Administration:

  • Sternum
  • Distal & Proximal Tibia
  • Distal Femur
  • Calcaneus
  • Head of Humerus

By Technology:

  • Manual
  • Automatic
    • Impact Driven
    • Power Drill

By End User:

  • EMS
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Care Centers

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The market is expected to grow from US$ 3.8 Bn in 2021 to US$ 7.9 Bn in 2031, rising at a CAGR of 7.6% over the forecast period (2021-2031).

The global intraosseous infusion device market is projected to be driven by the increasing demand for vascular access devices and quality emergency care.

North America currently holds the dominant share of 26.6% in the intraosseous infusion devices market.

The intraosseous infusion devices market in ASEAN is likely to grow at a CAGR of 7.0% during the forecast period, from 2021 to 2031. 

The primary focus for emergency settings is to stabilize the patient from a life-threatening event and refer them to a primary healthcare center immediately for further desired medical intervention. To support this, governments across various countries around the world are prioritizing emergency attention for raising healthcare standards. Improvement in standards of pre-hospital emergency settings in developing countries is driving the intraosseous infusion device.

The Japan market is expected to exhibit healthy growth at 7.4% CAGR during the forecast period.

U.S., Canada, Japan, China, and Russia are the top 5 countries that are driving the demand for Intraosseous infusion device s.

Leading companies offering intraosseous infusion devices are Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Technology Roadmap

    3.3. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Outlook

        4.1.3. Per Capita Healthcare Expenditure Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Increasing Emergency medical cases

        4.2.2. Increase in cardiovascular disease

        4.2.3. Advancements in Intraosseous infusion devices

        4.2.4. Adoption Rate for Intraosseous infusion devices

    4.3. Value Chain

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 Economic analysis

    5.4. COVID19 and Impact Analysis, by Country

    5.5. 2020 Market Scenario

6. Key Success Factors

    6.1. Product Adoption & Awareness Analysis

    6.2. Product USPs / Features

    6.3. Recent Product Launches

    6.4. Value Chain Analysis

    6.5. Key Promotion Strategies by Manufacturers

7. Market Demand (in Volume ‘000 Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Volume (‘000 Units) Analysis, 2016-2020

    7.2. Current and Future Market Volume (‘000 Units) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Intraosseous Infusion Devices Market Pricing Analysis

    8.1. Regional Pricing Analysis , By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Intraosseous Infusion Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (In Value or Size in US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Product, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Forecast By Product , 2021-2031

        10.3.1. B.I.G

        10.3.2. FAST1

        10.3.3. EZ-IO

        10.3.4. FASTR

        10.3.5. IO Needles

        10.3.6. Others

    10.4. Market Attractiveness Analysis By Product

11. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) and Forecast By Route of Administration , 2021-2031

        11.3.1. Sternum

        11.3.2. Distal & Proximal Tibia

        11.3.3. Distal Femur

        11.3.4. Calcaneus

        11.3.5. Head of Humerus

    11.4. Market Attractiveness Analysis By Route of Administration

12. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Technology

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Technology, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) and Forecast By Technology , 2021-2031

        12.3.1. Manual

        12.3.2. Automatic

        12.3.3. Impact Driven

        12.3.4. Power Drill

Market Attractiveness Analysis By Technology

13. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By End user

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020

    13.3. Current and Future Market Size (US$ Mn) and Forecast By End User , 2021-2031

        13.3.1. EMS

        13.3.2. Hospitals

        13.3.3. Ambulatory Surgical Centers

        13.3.4. Cardiac Care Centers

    13.4. Market Attractiveness Analysis By End User

14. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

    14.3. Current and Future Market Size (US$ Mn) and Forecast By Region , 2021-2031

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. MEA

    14.4. Market Attractiveness Analysis By Region

15. North America Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units)Trend Analysis by Market Taxonomy, 2016-2020

    15.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031

        15.3.1. By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Product

        15.3.3. By Route of Administration

        15.3.4. By Technology

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Route of Administration

        15.4.4. By Technology

        15.4.5. By End User

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Latin America Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units)Trend Analysis by Market Taxonomy, 2016-2020

    16.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Product

        16.3.3. By Route of Administration

        16.3.4. By Technology

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Route of Administration

        16.4.4. By Technology

        16.4.5. By End User

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Europe Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020

    17.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units)Forecast by Market Taxonomy, 2021-2031

        17.3.1. By Country

            17.3.1.1. U.K

            17.3.1.2. Germany

            17.3.1.3. France

            17.3.1.4. Italy

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Russia

            17.3.1.8. Rest of Europe

        17.3.2. By Product

        17.3.3. By Route of Administration

        17.3.4. By Technology

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Route of Administration

        17.4.4. By Technology

        17.4.5. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. South Asia Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020

    18.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Product

        18.3.3. By Route of Administration

        18.3.4. By Technology

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Route of Administration

        18.4.4. By Technology

        18.4.5. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. East Asia Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020

    19.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Product

        19.3.3. By Route of Administration

        19.3.4. By Technology

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Route of Administration

        19.4.4. By Technology

        19.4.5. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Oceania Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020

    20.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Product

        20.3.3. By Route of Administration

        20.3.4. By Technology

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Route of Administration

        20.4.4. By Technology

        20.4.5. By End User

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031

    21.1. Introduction

    21.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020

    21.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. South Africa

            21.3.1.3. Rest of Middle East and Africa

        21.3.2. By Product

        21.3.3. By Route of Administration

        21.3.4. By Technology

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Product

        21.4.3. By Route of Administration

        21.4.4. By Technology

        21.4.5. By End User

    21.5. Key Market Participants - Intensity Mapping

    21.6. Drivers and Restraints - Impact Analysis

22. Emerging & Key Countries Intraosseous Infusion Devices Market Analysis – 2021 & 2031

    22.1. Introduction

        22.1.1. Market Value Proportion Analysis, By Key Countries

        22.1.2. Global Vs. Country Growth Comparison

    22.2. U.S. Intraosseous Infusion Devices Market Analysis

        22.2.1. By Product

        22.2.2. By Route of Administration

        22.2.3. By Technology

        22.2.4. By End User

    22.3. Canada Intraosseous Infusion Devices Market Analysis

        22.3.1. By Product

        22.3.2. By Route of Administration

        22.3.3. By Technology

        22.3.4. By End User

    22.4. Mexico Intraosseous Infusion Devices Market Analysis

        22.4.1. By Product

        22.4.2. By Route of Administration

        22.4.3. By Technology

        22.4.4. By End User

    22.5. Brazil Intraosseous Infusion Devices Market Analysis

        22.5.1. By Product

        22.5.2. By Route of Administration

        22.5.3. By Technology

        22.5.4. By End User

    22.6. Germany Intraosseous Infusion Devices Market Analysis

        22.6.1. By Product

        22.6.2. By Route of Administration

        22.6.3. By Technology

        22.6.4. By End User

    22.7. Italy Intraosseous Infusion Devices Market Analysis

        22.7.1. By Product

        22.7.2. By Route of Administration

        22.7.3. By Technology

        22.7.4. By End User

    22.8. France Intraosseous Infusion Devices Market Analysis

        22.8.1. By Product

        22.8.2. By Route of Administration

        22.8.3. By Technology

        22.8.4. By End User

    22.9. U.K. Intraosseous Infusion Devices Market Analysis

        22.9.1. By Product

        22.9.2. By Route of Administration

        22.9.3. By Technology

        22.9.4. By End User

    22.10. Spain Intraosseous Infusion Devices Market Analysis

        22.10.1. By Product

        22.10.2. By Route of Administration

        22.10.3. By Technology

        22.10.4. By Technology

        22.10.5. By End User

    22.11. BENELUX Intraosseous Infusion Devices Market Analysis

        22.11.1. By Product

        22.11.2. By Route of Administration

        22.11.3. By Technology

        22.11.4. By End User

    22.12. Russia Intraosseous Infusion Devices Market Analysis

        22.12.1. By Product

        22.12.2. By Route of Administration

        22.12.3. By Technology

        22.12.4. By End User

    22.13. China Intraosseous Infusion Devices Market Analysis

        22.13.1. By Product

        22.13.2. By Route of Administration

        22.13.3. By Technology

        22.13.4. By End User

    22.14. Japan Intraosseous Infusion Devices Market Analysis

        22.14.1. By Product

        22.14.2. By Route of Administration

        22.14.3. By Technology

        22.14.4. By End User

    22.15. South Korea Intraosseous Infusion Devices Market Analysis

        22.15.1. By Product

        22.15.2. By Route of Administration

        22.15.3. By Technology

        22.15.4. By End User

    22.16. India Intraosseous Infusion Devices Market Analysis

        22.16.1. By Product

        22.16.2. By Route of Administration

        22.16.3. By Technology

        22.16.4. By End User

    22.17. ASEAN Intraosseous Infusion Devices Market Analysis

        22.17.1. By Product

        22.17.2. By Route of Administration

        22.17.3. By Technology

        22.17.4. By End User

    22.18. Australia and New Zealand Intraosseous Infusion Devices Market Analysis

        22.18.1. By Product

        22.18.2. By Route of Administration

        22.18.3. By Technology

        22.18.4. By End User

    22.19. GCC Countries Intraosseous Infusion Devices Market Analysis

        22.19.1. By Product

        22.19.2. By Route of Administration

        22.19.3. By Technology

        22.19.4. By End User

    22.20. Turkey Intraosseous Infusion Devices Market Analysis

        22.20.1. By Product

        22.20.2. By Route of Administration

        22.20.3. By Technology

        22.20.4. By End User

    22.21. South Africa Intraosseous Infusion Devices Market Analysis

        22.21.1. By Product

        22.21.2. By Route of Administration

        22.21.3. By Technology

        22.21.4. By End User

23. Market Structure Analysis

    23.1. Market Analysis by Tier of Companies

    23.2. Market Share Analysis of Top Players

    23.3. Market Presence Analysis

        23.3.1. By Regional Footprint of Players

        23.3.2. Product Footprint by Players

        23.3.3. Channel Footprint by Players

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Competition Benchmarking

    24.3. Competition Deep Dive

        24.3.1. Pyng medical Corp.,

            24.3.1.1. Overview

            24.3.1.2. Type Portfolio

            24.3.1.3. Sales Footprint

            24.3.1.4. Analyst commentary

            24.3.1.5. Strategy Overview

                24.3.1.5.1. Marketing Strategy

                24.3.1.5.2. Product Strategy

                24.3.1.5.3. Channel Strategy

        24.3.2. Cook Medical Incorporated

            24.3.2.1. Overview

            24.3.2.2. Type Portfolio

            24.3.2.3. Sales Footprint

            24.3.2.4. Analyst commentary

            24.3.2.5. Strategy Overview

                24.3.2.5.1. Marketing Strategy

                24.3.2.5.2. Product Strategy

                24.3.2.5.3. Channel Strategy

        24.3.3. PerSys Medical

            24.3.3.1. Overview

            24.3.3.2. Type Portfolio

            24.3.3.3. Sales Footprint

            24.3.3.4. Analyst commentary

            24.3.3.5. Strategy Overview

                24.3.3.5.1. Marketing Strategy

                24.3.3.5.2. Product Strategy

                24.3.3.5.3. Channel Strategy

        24.3.4. Aero Healthcare

            24.3.4.1. Overview

            24.3.4.2. Type Portfolio

            24.3.4.3. Sales Footprint

            24.3.4.4. Analyst commentary

            24.3.4.5. Strategy Overview

                24.3.4.5.1. Marketing Strategy

                24.3.4.5.2. Product Strategy

                24.3.4.5.3. Channel Strategy

        24.3.5. Teleflex, Inc.

            24.3.5.1. Overview

            24.3.5.2. Type Portfolio

            24.3.5.3. Sales Footprint

            24.3.5.4. Analyst commentary

            24.3.5.5. Strategy Overview

                24.3.5.5.1. Marketing Strategy

                24.3.5.5.2. Product Strategy

                24.3.5.5.3. Channel Strategy

        24.3.6. Becton Dickinson and Co.

            24.3.6.1. Overview

            24.3.6.2. Type Portfolio

            24.3.6.3. Sales Footprint

            24.3.6.4. Analyst commentary

            24.3.6.5. Strategy Overview

                24.3.6.5.1. Marketing Strategy

                24.3.6.5.2. Product Strategy

                24.3.6.5.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 2: Global Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031

Table 3: Global Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 4: Global Intraosseous Infusion Devices Market Value (US$ Mn), Route of Administration, 2021 - 2031

Table 5: Global Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 6: Global Intraosseous Infusion Devices Market Value (US$ Mn), by Region, 2021 - 2031

Table 7: North America Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 8: North America Intraosseous Infusion Devices Market Volume (Mn units), by Product Segment, 2021 - 2031

Table 9: North America Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 10: North America Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 11: North America Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 12: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031

Table 13: Latin America Intraosseous Infusion Devices Market Volume (Mn units), by Country, 2021 - 2031

Table 14: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 15: Latin America Intraosseous Infusion Devices Market Volume (Mn units), by Product Segment, 2021 - 2031

Table 16: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 17: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 18: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 19: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031

Table 20: Europe Intraosseous Infusion Devices Market Volume (Mn Units), by Country, 2021 - 2031

Table 21: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 22: Europe Intraosseous Infusion Devices Market Volume (Mn units), by Product Segment, 2021 - 2031

Table 23: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 24: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 25: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 26: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031

Table 27: South Asia Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031

Table 28: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 29: South Asia Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031

Table 30: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 31: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Automatic Technology Sub-Segment, 2021 - 2031

Table 32: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 33: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 34: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031

Table 35: East Asia Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031

Table 36: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 37: East Asia Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031

Table 38: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 39: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 40: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 41: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031

Table 42: Oceania Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031

Table 43: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 44: Oceania Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031

Table 45: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 46: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 47: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Table 48: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031

Table 49: MEA Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031

Table 50: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031

Table 51: MEA Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031

Table 52: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031

Table 53: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031

Table 54: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Intraosseous Infusion Devices Market Volume ('000 Units) Analysis, 2016-2020

Figure 2: Global Intraosseous Infusion Devices Market Volume ('000 Units) & Y-O-Y Growth (%) Analysis, 2021-2031

Figure 3: Global Average Pricing Analysis Benchmark USD (Unit)-2020

Figure 4: Global Intraosseous Infusion Devices Market Value (US% Mn) Analysis, 2016-2020

Figure 5: Global Intraosseous Infusion Devices Market Value (US% Mn) & Y-O-Y Growth (%) Analysis, 2021-2031

Figure 6: Global Intraosseous Infusion Devices Market Absolute $ Opportunity, 2021 - 2031

Figure 7: Global Intraosseous Infusion Devices Market Value Share, by Product, 2021 - 2031

Figure 8: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 9: Global Intraosseous Infusion Devices Market Value Share, by Technology, 2021 - 2031

Figure 10: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 11: Global Intraosseous Infusion Devices Market Value Share, by Route of administration, 2021 - 2031

Figure 12: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 13: Global Intraosseous Infusion Devices Market Value Share, by End User, 2021 - 2031

Figure 14: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 15: Global Intraosseous Infusion Devices Market Value Share, by Region, 2021 - 2031

Figure 16: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Region, 2021 - 2031

Figure 17: North America Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 18: North America Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 19: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 20: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 21: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 22: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 23: Latin America Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 24: Latin America Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 25: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 26: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 27: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 28: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 29: Europe Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 30: Europe Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 31: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031

Figure 32: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 33: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 34: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 35: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 36: South Asia Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 37: South Asia Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 38: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031

Figure 39: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 40: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 41: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 42: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 43: East Asia Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 44: East Asia Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 45: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031

Figure 46: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 47: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 48: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 49: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 50: Oceania Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 51: Oceania Intraosseous Infusion Devices Market Value Share By Product, 2021 - 2031

Figure 52: Oceania Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 53: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 54: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 55: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 56: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031

Figure 57: MEA Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031

Figure 58: MEA Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 59: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031

Figure 60: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031

Figure 61: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031

Figure 62: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031

Figure 63: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 – 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Home Healthcare Market

Published : February 2022

Healthcare

MRI - Compatible IV Infusion Pump Systems Market

Published : July 2017

Healthcare

Pressure Infusion Bags Market

Published : January 2022

Healthcare

Infusion Pumps Market

Published : February 2022

Google translate

Intraosseous Infusion Devices Market